Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05603273 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers

StatusCompleted
PhaseNot applicable
Started2023-12-13
View on ClinicalTrials.gov ↗

Amendment history

2026-09-16
notable
Trial completed
Final enrollment: 3 participants — 8% of the 40 planned
Study completion confirmed: June 2025 (last estimated June 2026)
2025-09-17
minor
Study Status, Oversight, Contacts/Locations v5
Study sitescontacts updated at 1 of 1 site
2024-10-29
minor
Study Status v4
Re-verified, no change to tracked fields
2024-01-29
minor
Study Status v3
Start dateestimated 2024-10-01→confirmed 2023-12-13
2023-11-10
minor
Study Status v2
Start date2023-10-01→2024-10-01
2023-08-24
minor
Study Status v1
Start date2022-10-26→2023-10-01
2022-10-31
minor
Original filing
4,247 trials monitored
See 176 trials at risk
2,082 trials monitored
See 101 trials at risk
The goal of this study is to improve the therapeutic management of diabetic foot ulcers (DFU). The main questions to answer are if a program of non-weight bearing exercise helps the DFU heal faster than standard wound care. This randomized clinical trial will determine how blood flow to the ulcer and whole body metabolism may be improved with exercise. Participants will be randomized to either exercise + standard wound care or standard wound care alone and undergo testing for leg blood flow, fitness and measures of metabolism through blood draws. The intervention period is 6-weeks. Eligible participants must have an existing foot ulcer uncomplicated by infection and be medically cleared to exercise.
Trial Details
NCT Number NCT05603273
Lead Sponsor University of Michigan
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Type2diabetes, Foot Ulcer
Enrollment 3 participants
Start Date 2023-12-13
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-15